Yes, dry eye is officially classified as a disease. The Tear Film & Ocular Surface Society, the leading international research body on the topic, defines dry eye as “a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film.” That distinction matters because it separates the chronic condition from the temporary dryness most people feel after a long flight or a few hours staring at a screen. Dry eye disease (often abbreviated DED) involves ongoing disruption to how your tears are produced, spread, and maintained, and it affects somewhere between 5% and 50% of adults worldwide depending on how it’s measured.
Why It’s a Disease, Not Just Dryness
Everyone experiences dry, irritated eyes from time to time. Windy weather, air conditioning, and long stretches of screen use can all temporarily reduce tear quality. That kind of occasional discomfort typically resolves on its own once the trigger is gone.
Dry eye disease is different. It involves a self-reinforcing cycle of tear film instability, increased salt concentration in your tears, inflammation on the surface of the eye, and sometimes nerve damage that distorts how your eyes sense moisture. Once this cycle takes hold, it doesn’t simply go away when you step outside or take a break from your computer. The inflammation and surface damage feed each other, which is why eye doctors treat it as a chronic condition rather than a passing irritation. If you’ve had red, burning, tired, or painful eyes for weeks or longer, that pattern points toward disease rather than a temporary episode.
How the Tear Film Breaks Down
Your tear film has three layers that work together: a mucin layer that helps tears stick to the eye’s surface, a watery (aqueous) layer that makes up the bulk of the tear and delivers oxygen and nutrients, and an oily (lipid) layer on top that slows evaporation. A dysfunction in any one of these layers can trigger dry eye disease.
Clinicians generally sort the condition into two major types. Aqueous deficient dry eye means your tear glands aren’t producing enough of the watery layer. This form sometimes signals an underlying autoimmune disorder that can gradually destroy the glands responsible for tear production. Evaporative dry eye, which is more common, occurs when the tiny oil glands along your eyelid margins (called meibomian glands) stop working properly. Without enough oil on the surface, tears evaporate too quickly and become unstable. Over time, the chronic inflammation from evaporative dry eye can further damage those oil glands, making the problem progressively worse if left unmanaged.
Screen Time and Modern Risk Factors
The global rise in screen use has pushed dry eye disease into a broader and younger population. Research published in 2020 found that prolonged use of digital screens shares key features with the evaporative subtype of dry eye, including reduced blink rates, inflammatory changes on the eye’s surface, and measurable drops in tear stability. When you focus on a screen, your blink rate drops significantly, and incomplete blinks become more common. That means the tear film isn’t being refreshed as often as it should be, accelerating evaporation and exposing the cornea to air.
U.S. prevalence data shows the condition isn’t limited to older adults. One estimate found that roughly 35% of people aged 18 to 39 had dry eye, while about 33% of those 50 and older did. The numbers vary depending on how the condition is defined, but the pattern is clear: this is not just an aging-related problem.
How Dry Eye Disease Is Diagnosed
There’s no single test that confirms dry eye disease. Instead, eye care specialists use a combination of assessments to build a picture of what’s happening on your eye’s surface.
- Tear production tests. The most common is the Schirmer test, where small strips of blotting paper are placed under your lower eyelids. After five minutes, the doctor measures how much of the strip your tears have soaked. A similar option, the phenol red thread test, uses a dye-coated thread placed on the lower lid for 15 seconds.
- Tear stability tests. Special dyes are added to your tears so the doctor can watch how quickly the tear film breaks apart after a blink. Faster breakup means less stable tears.
- Osmolarity testing. This measures the ratio of salt particles to water in your tears. Higher osmolarity (meaning less water relative to dissolved particles) is a hallmark of dry eye disease.
- Surface staining. Dye drops reveal damaged or dry patches on the cornea, showing where the tear film is failing to protect the surface.
- Biomarker analysis. Tear samples can be tested for specific proteins associated with inflammation and tissue breakdown.
These tests help your doctor determine not just whether you have dry eye disease, but which type you have and how severe it is, which directly shapes treatment.
What Happens Without Treatment
Mild dry eye is uncomfortable. Severe, untreated dry eye can threaten your vision. When the tear film consistently fails to protect the cornea, debris can scratch its surface. If bacteria enter those scratches, a corneal ulcer (an open sore on the clear front layer of the eye) can develop. Ulcers are treatable with medicated eye drops when caught early, but if they’re ignored, they can scar the eye and cause partial or complete vision loss.
Even short of that worst case, chronic dry eye commonly causes blurry or fluctuating vision that people mistake for a change in their glasses prescription. Double vision can develop over time. These visual symptoms tend to worsen gradually, which makes them easy to dismiss until they start interfering with driving or reading.
Managing a Chronic Condition
Dry eye disease is generally not curable. It’s a condition you manage over time, much like high blood pressure or allergies. Treatment typically starts with lifestyle adjustments: reducing environmental dryness, taking regular breaks from screens, and using artificial tears consistently, even on days when your eyes feel fine. The goal is to keep the tear film stable enough to prevent the inflammation cycle from ramping up.
When over-the-counter drops aren’t enough, prescription treatments target the underlying inflammation that drives the disease. Some work by calming the immune response on the eye’s surface, while others help your body produce more of its own natural tears. For people with meibomian gland dysfunction, in-office procedures can help clear blocked oil glands and restore the lipid layer.
The key shift in how doctors approach dry eye is treating it as an ongoing disease process rather than a cosmetic nuisance. That means proactive, sustained management instead of reaching for eye drops only when symptoms flare. For most people, a consistent routine keeps the condition stable and prevents the kind of corneal damage that leads to serious complications.